Although Stribild costs 33 percent more than the list price for Atripla, RW Baird analyst Thomas Russo called the pricing appropriate, noting the cost is similar to other, less convenient, multi-tablet HIV regimens.
FORBES: Backlash Over New Gilead AIDS Drug Begins